Liquidia Corp (LQDA)
12.70
-0.04
(-0.31%)
USD |
NASDAQ |
May 17, 16:00
12.70
0.00 (0.00%)
After-Hours: 20:00
Liquidia Cash from Operations (Quarterly): -24.87M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -24.87M |
December 31, 2023 | -15.98M |
September 30, 2023 | -11.56M |
June 30, 2023 | -5.564M |
March 31, 2023 | -8.457M |
December 31, 2022 | -4.603M |
September 30, 2022 | -5.774M |
June 30, 2022 | -8.429M |
March 31, 2022 | -9.782M |
December 31, 2021 | -7.559M |
September 30, 2021 | -5.831M |
June 30, 2021 | -8.259M |
March 31, 2021 | -12.39M |
December 31, 2020 | -14.09M |
September 30, 2020 | -12.51M |
Date | Value |
---|---|
June 30, 2020 | -13.11M |
March 31, 2020 | -14.44M |
December 31, 2019 | -14.06M |
September 30, 2019 | -11.95M |
June 30, 2019 | -12.16M |
March 31, 2019 | -10.11M |
December 31, 2018 | -8.329M |
September 30, 2018 | -6.280M |
June 30, 2018 | -7.222M |
March 31, 2018 | -10.00M |
December 31, 2017 | -4.662M |
September 30, 2017 | -5.253M |
June 30, 2017 | -5.333M |
March 31, 2017 | -9.042M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-24.87M
Minimum
Mar 2024
-4.603M
Maximum
Dec 2022
-11.07M
Average
-11.76M
Median
Cash from Operations (Quarterly) Benchmarks
United Therapeutics Corp | 376.50M |
AIM ImmunoTech Inc | -9.758M |
Perspective Therapeutics Inc | 13.85M |
Protalix BioTherapeutics Inc | 4.188M |
Armata Pharmaceuticals Inc | -10.58M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -0.624M |
Cash from Financing (Quarterly) | 99.67M |
Free Cash Flow | -69.52M |
Free Cash Flow Per Share (Quarterly) | -0.3381 |
Free Cash Flow to Equity (Quarterly) | -25.49M |
Free Cash Flow Yield | -8.08% |